Journal of Nutrition and Health

The Korean Nutrition Society (한국영양학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of xylooligosaccharide-sugar mixture on defecation frequency and symptoms in young women with constipation: a randomized, double-blind, placebo-controlled trial

자일로올리고당을 함유한 설탕이 20대 여성의 변비 개선에 미치는 효과: 이중맹검 연구

  • Received : 2014.12.29
  • Accepted : 2015.01.26
  • Published : 2015.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: To investigate the effects of the intake of xylooligosaccharide-sugar mixture (XOS) on defecation frequency and symptoms in 56 young women (mean age of 22.1 years old) with constipation. Methods: Two experiments were conducted. In experiment 1, a randomized double-blind study was performed to evaluate the effect of 6 weeks' intake of 10 g sucrose containing 7% xylooligosaccharide or 10 g sucrose on constipation. In experiment 2, 24 g coffee mixture containing 12.8 g plant cream and 11.2 g xylooligosaccharide-sugar mixture was consumed by the subjects. During the study, the clinical efficacy was assessed by using a daily diary. The subjects indicated the number of frequencies they defecated in a day and the clinical symptom scores. Results: In experiment 1, the mean frequency of defecations was 2.07 in the pretreatment week and increased significantly to 4.05, 4.42, 4.84, 4.84, and 4.05 in weeks 2 to 6 of XOS intake, in comparison with the 3-3.67 with sucrose intake (sucrose, SUC). In experiment 2, the mean frequency of defecations significantly increased from 2.47 in the pretreatment week to 4.11-5.67 in weeks 1-6 of XOS intake. The occurrence of very loose or loose stools in the XOS group was significantly increased in weeks 5 and 6, compared with the pretreatment week and SUC group. XOS intake significantly alleviated the abdominal displeasure and feeling of residual stool leftness in weeks 2, 3, 5, and 6, while SUC did so in weeks 4 and 6 (p < 0.05). The coffee mixture containing xylooligosaccharide-sugar mixture reduced the abdominal displeasure and feeling of residual stool leftness from week 3 until the end of the experiment (p < 0.05). Conclusion: Our results suggest that xylooligosaccharide-sugar mixture intake was effective, without adverse effects, for the alleviation of constipation in the young women in this study.

본 연구는 자일로올리고당을 설탕에 혼합하여 변비를 앓고 있는 젊은 여성을 대상으로 변비개선효과를 확인하였다. 평균연령 22.1세인 젊은 여성 56명을 대상으로 실험 1에서는 설탕을 플라시보로 하는 이중맹검 임상연구를 통해 자일로올리고당 0.7 g이 함유된 설탕 10 g (n = 19명) 또는 설탕 10 g (n = 19명)을 블랙커피와 함께 복용하도록 하였고, 실험 2에서는 자일로올리고당 0.4 g 함유한 설탕 5.6 g과 1.6 g의 커피, 4.8 g의 식물성 크림이 함유된 커피믹스를 1일 2회씩 6주간 섭취하도록 하였다 (n = 18명). 섭취결과 XOS군과 XOSmix군의 경우 섭취전 주간 배변횟수가 2.47회에서 섭취 1주째부터 증가하여 섭취 6주째에는 주간 배변횟수가 4.11회와 5.67회로 각각 증가하였다. XOS와 XOS 함유 커피믹스는 통계적으로 유의하게 복부 불쾌감과 잔변감을 개선하였으며, 배변횟수의 증가는 섭취초반 부터 효과가 있는 것으로 나타났다. 따라서 XOS는 0.7 g의 적은양으로도 변비를 개선하는 효과가 있는 것으로 나타나 음료에 기능성을 갖춘 감미료로서의 활용이 기대된다.

Keywords

References

  1. Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther 2007; 25(5): 599-608. https://doi.org/10.1111/j.1365-2036.2006.03238.x
  2. Kassinen A, Krogius-Kurikka L, Makivuokko H, Rinttila T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133(1): 24-33. https://doi.org/10.1053/j.gastro.2007.04.005
  3. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130(5): 1480-1491. https://doi.org/10.1053/j.gastro.2005.11.061
  4. Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol 2011; 106(9): 1582-1591. https://doi.org/10.1038/ajg.2011.164
  5. Sanchez MI, Bercik P. Epidemiology and burden of chronic constipation. Can J Gastroenterol 2011; 25(Suppl B): 11B-15B. https://doi.org/10.1155/2011/125491
  6. Nellesen D, Chawla A, Oh DL, Weissman T, Lavins BJ, Murray CW. Comorbidities in patients with irritable bowel syndrome with constipation or chronic idiopathic constipation: a review of the literature from the past decade. Postgrad Med 2013; 125(2): 40-50. https://doi.org/10.3810/pgm.2013.03.2640
  7. Gallegos-Orozco JF, Foxx-Orenstein AE, Sterler SM, Stoa JM. Chronic constipation in the elderly. Am J Gastroenterol 2012; 107(1): 18-25. https://doi.org/10.1038/ajg.2011.349
  8. Nyberg C, Hendel J, Nielsen OH. The safety of osmotically acting cathartics in colonic cleansing. Nat Rev Gastroenterol Hepatol 2010; 7(10): 557-564. https://doi.org/10.1038/nrgastro.2010.136
  9. Olafsdottir LB, Gudjonsson H, Jonsdottir HH, Jonsson JS, Bjornsson E, Thjodleifsson B. Irritable bowel syndrome: physicians' awareness and patients' experience. World J Gastroenterol 2012; 18(28): 3715-3720. https://doi.org/10.3748/wjg.v18.i28.3715
  10. Hart AL, Stagg AJ, Kamm MA. Use of probiotics in the treatment of inflammatory bowel disease. J Clin Gastroenterol 2003; 36(2): 111-119. https://doi.org/10.1097/00004836-200302000-00005
  11. Kinugasa A, Matsushita S. Effect of bifidobacterial material on abnormal evacuative symptoms. J New Rem Clin 1993; 42: 2181-2187.
  12. Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995; 108(4): 975-982. https://doi.org/10.1016/0016-5085(95)90192-2
  13. Ford AC, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Moayyedi P. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 2014; 109(10): 1547-1561. https://doi.org/10.1038/ajg.2014.202
  14. Akpinar O, Erdogan K, Bostanci S. Enzymatic production of Xylooligosaccharide from selected agricultural wastes. Food Bioprod Process 2009; 87(2): 145-151. https://doi.org/10.1016/j.fbp.2008.09.002
  15. Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004; 17(2): 259-275. https://doi.org/10.1079/NRR200479
  16. Macfarlane S, Macfarlane GT, Cummings JH. Review article: prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther 2006; 24(5): 701-714. https://doi.org/10.1111/j.1365-2036.2006.03042.x
  17. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 2006; 40(3): 235-243. https://doi.org/10.1097/00004836-200603000-00015
  18. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004; 79(4): 537-543. https://doi.org/10.1093/ajcn/79.4.537
  19. Korea Rural Economic Institute. Food balance sheet 2012. Seoul: Korea Rural Economic Institute; 2013.
  20. Shin HL. Customer attitude survey: beverage purchasing behaviors and preference [dissertation]. Seoul: Sejong University; 2009.
  21. Ministry of Food, Agriculture, Forestry and Fisheries, Korea Agro-Fisheries and Food Trade Corporation. 2012 Processed food segments status report: coffeemix. Seoul: Korea Agro-Fisheries and Food Trade Corporation; 2012.
  22. Ministry of Food, Agriculture, Forestry and Fisheries, Korea Agro-Fisheries and Food Trade Corporation. 2013 Processed food segments status report: coffee. Seoul: Korea Agro-Fisheries and Food Trade Corporation; 2013.
  23. Korea Consumer Agency. A report on the comparison of the component of coffee mixtures [Internet]. Eumseong: Korea Consumer Agency; 2014 [cited 2014 Jul 9]. Available from: http://www.kca.go.kr/brd/m_32/view.do?seq=1634.
  24. Malik VS, Popkin BM, Bray GA, Despres JP, Hu FB. Sugarsweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010; 121(11): 1356-1364. https://doi.org/10.1161/CIRCULATIONAHA.109.876185
  25. Alonso S, Setser C. Functional replacements for sugars in foods. Trends Food Sci Technol 1994; 5(5): 139-146. https://doi.org/10.1016/0924-2244(94)90119-8
  26. Drossman DA. Rome III: the new criteria. Chin J Dig Dis 2006; 7(4): 181-185. https://doi.org/10.1111/j.1443-9573.2006.00265.x
  27. Tateyama I, Hashii K, Johno I, Iino T, Hirai K, Suwa Y, Kiso Y. Effect of xylooligosaccharide intake on severe constipation in pregnant women. J Nutr Sci Vitaminol (Tokyo) 2005; 51(6): 445-448. https://doi.org/10.3177/jnsv.51.445
  28. Preston DM, Lennard-Jones JE. Severe chronic constipation of young women: 'idiopathic slow transit constipation'. Gut 1986; 27(1): 41-48. https://doi.org/10.1136/gut.27.1.41
  29. Chung YC, Hsu CK, Ko CY, Chan YC. Dietary intake of xylooligosaccharides improves the intestinal microbiota, fecal moisture, and pH value in the elderly. Nutr Res 2007; 27(12): 756-761. https://doi.org/10.1016/j.nutres.2007.09.014
  30. Okazaki M, Fujikawa S, Matsumoto N. Effect of xylooligosaccharide on the growth of bifidobacteria. Bifidobact Microflora 1990; 9(2): 77-86. https://doi.org/10.12938/bifidus1982.9.2_77
  31. Iino T, Nishijima Y, Sawada S, Sasaki H, Harada H, Suwa Y, Kiso Y. Improvement of constipation by a small amount of xylooligosaccharides ingestion in adult women. J Jpn Assoc Diet Fiber Res 1997; 1(1): 19-24.
  32. Kobayashi T, Okazaki M, Fujikawa S, Koga K. Effect of xylooligosaccharides on feces of men. Nippon Nogeikagaku Kaishi 1991; 65(11): 1651-1653. https://doi.org/10.1271/nogeikagaku1924.65.1651
  33. Faruqui AA, Joshi C. Lactitol: a review of its use in the treatment of constipation. Int J Recent Adv Pharm Res 2012; 2(1): 1-5.
  34. Dukas L, Willett WC, Giovannucci EL. Association between physical activity, fiber intake, and other lifestyle variables and constipation in a study of women. Am J Gastroenterol 2003; 98(8): 1790-1796. https://doi.org/10.1111/j.1572-0241.2003.07591.x
  35. Jones MP, Talley NJ, Nuyts G, Dubois D. Lack of objective evidence of efficacy of laxatives in chronic constipation. Dig Dis Sci 2002; 47(10): 2222-2230. https://doi.org/10.1023/A:1020131126397
  36. Zoppi G, Cinquetti M, Luciano A, Benini A, Muner A, Bertazzoni Minelli E. The intestinal ecosystem in chronic functional constipation. Acta Paediatr 1998; 87(8): 836-841. https://doi.org/10.1111/j.1651-2227.1998.tb01547.x
  37. Qiang X, YongLie C, QianBing W. Health benefit application of functional oligosaccharides. Carbohydr Polym 2009; 77(3): 435-441. https://doi.org/10.1016/j.carbpol.2009.03.016
  38. Okazaki M, Koda H, Izumi R, Fujikawa S, Matsumoto N. In vitro digestibility and in vivo utilization of xylobiose. Nihon Eiyo Shokuryo Gakkai Shi 1991; 44(1): 41-44. https://doi.org/10.4327/jsnfs.44.41
  39. Wintola OA, Sunmonu TO, Afolayan AJ. The effect of Aloe ferox Mill. in the treatment of loperamide-induced constipation in Wistar rats. BMC Gastroenterol 2010; 10: 95. https://doi.org/10.1186/1471-230X-10-95
  40. Christensen J. Chapter 39 Possible effects of laxatives on the nerve plexuses of the colon. In: Kamm MA, Lennard-Jones JE, editors. Constipation. Petersfield: Wrightson Biomedical Pub.; 1994. p. 321-326.

Cited by

  1. 자일로바이오스를 함유한 설탕이 젊은 여성의 변비 개선에 미치는 효과 vol.50, pp.1, 2015, https://doi.org/10.4163/jnh.2017.50.1.41
  2. Bifidobacterium longum과 자일로올리고당을 포함한 synbiotics 섭취가 건강한 성인의 변내 균총과 배변 상태에 미치는 영향 vol.53, pp.4, 2015, https://doi.org/10.4163/jnh.2020.53.4.390